Please login to the form below

Not currently logged in
Email:
Password:

Syros appoints Moderna CEO to board

Stéphane Bancel also has experience at bioMérieux and Lilly
Syros Stephane Bancel

The founding CEO of Moderna Therapeutics, Stéphane Bancel, has joined the board of Syros Pharmaceuticals.

Syros, which focuses on controlling a person's genes to treat cancer and other diseases, will benefit from Bancel's work in RNA therapeutics at Moderna.

The company's CEO Nancy Simonian said: “Stéphane has established an exceptional track record of accomplishment in our industry. His successes in financing and building companies as well as in creating value are widely admired.”

Bancel joined Moderna in 2011, the year after its formation. Notable achievements as CEO include securing a licensing partnership with AstraZeneca potentially worth more than $400m.

Prior to serving as Moderna's CEO, Bancel spent four years as CEO of bioMérieux.

He also spent six years at Lilly, including a spell as country manager for Belgium.

Commenting on his appointment to the board of Syros, he said: “Syros' leadership in understanding gene control opens entirely new avenues to treat cancer and other serious diseases.

“The company's revolutionary approach creates significant opportunity to impact health and create value.”

27th November 2013

From: Research, Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
90TEN

90TEN is an award-winning healthcare communications consultancy that puts people at the heart of everything we do. Our Life.Changing. campaigns...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics